menu
    • menu

    Company profile for Ferrer Internacional

    NEW Drugs in Dev: 13
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Ferrer has joined the Barcelona City Council, EADA Business School and B Lab Spain in the Barcelona+B initiative, a pioneering project in Spain to promote social and business transformation and promote a more prosperous, sustainable and inclusive city. Given the need to act against the climate emergency and social inequalities, Barcelona+B is a pioneering initiative in Spain that seeks to improve the social and environmenta...
    Ferrer has joined the Barcelona City Council, EADA Business School and B Lab Spain in the Barcelona+B initiative, a pioneering project in Spain to promote social and business transformation and promote a more prosperous, sustainable and inclusive city. Given the need to act against the climate emergency and social inequalities, Barcelona+B is a pioneering initiative in Spain that seeks to improve the social and environmental impact of companies and citizens, to turn them into the main agents of change and positive transformation.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Ferrer InternacionalGermany Flag
    Country
    Country
    Germany
    Address
    Address
    Kaiserstraße, 100 D-52134, Herzogenrath (Alemania)
    Telephone
    Telephone
    +4924075023110
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.ferrer.com/en
    Linkedin
    Linkedin
    https://www.linkedin.com/company/ferrerforgood/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/ferrerforgood

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    RDD

    RDD

    Not Confirmed

    envelop Contact Supplier

    RDD

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    IMPAHCT Marks 8th Edition for Rare Lung Diseases
    IMPAHCT Marks 8th Edition for Rare Lung Diseases

    30 Apr 2026

    // PRESS RELEASE

    https://www.ferrer.com/en/impahct-eight-edition-barcelona

    PRESS RELEASE
    30 Apr 2026
    Share Share
    Prilenia Ferrer Enroll First Patient In PREVAiLS Ph3 ALS Study
    Prilenia Ferrer Enroll First Patient In PREVAiLS Ph3 ALS Study

    30 Mar 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260330646991/en/Prilenia-and-Ferrer-Announce-First-Participant-Enrolled-in-the-PREVAiLS-Phase-3-Study-of-Pridopidine-in-ALS

    BUSINESSWIRE
    30 Mar 2026
    Share Share
    Ferrer, Prilenia Enroll First Patient in ALS Phase 3
    Ferrer, Prilenia Enroll First Patient in ALS Phase 3

    30 Mar 2026

    // PRESS RELEASE

    https://www.ferrer.com/en/Ferrer-and-Prilenia-Announce-First-Participant-Enrolled-in-the-PREVAiLS-Phase-3-Study-of-Pridopidine-in-ALS

    PRESS RELEASE
    30 Mar 2026
    Share Share
    Ferrer Recognized Among 2026's Most Ethical Companies
    Ferrer Recognized Among 2026's Most Ethical Companies

    18 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-18/ferrer-included-in-the-ranking-of-the-world-s-most-ethical-companies-in-2026

    PHARMIWEB
    18 Mar 2026
    Share Share
    Prilenia, Ferrer To Begin 'Prevails' Phase 3 ALS Study
    Prilenia, Ferrer To Begin 'Prevails' Phase 3 ALS Study

    11 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251211232354/en/Prilenia-and-Ferrer-Announce-FDA-Clearance-to-Start-the-PREVAiLS-Pivotal-Phase-3-Study-with-Pridopidine-in-ALS

    BUSINESSWIRE
    11 Dec 2025
    Share Share
    Ferrer has announced completion 220 patients for PROSPER study
    Ferrer has announced completion 220 patients for PROSPER study

    21 Oct 2025

    // PRESS RELEASE

    https://www.ferrer.com/en/Ferrer-completes-recruitment-of-220-patients-for-the-prosper-study-a-phase-ii-clinical-trial-in-progressive-supranuclear-palsy-psp-two-months-ahead-of-schedule

    PRESS RELEASE
    21 Oct 2025
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search